Immunogenicity Risk Assessment of Process-related Impurities in an Engineered T cell Receptor Cellular Product.
Mora J, Forman D, Hu J, Ijantkar A, Gokemeijer J, Kolaja KL, Picarillo C, Jawa V, Yue H, Lamy J, Denies S, Schockaert J, Ackaert C.
Mora J, et al. Among authors: hu j.
J Pharm Sci. 2024 May 18:S0022-3549(24)00188-6. doi: 10.1016/j.xphs.2024.05.018. Online ahead of print.
J Pharm Sci. 2024.
PMID: 38768755